About
"De-risking the commercialisation of Health-Tech innovations" We provide expert advice on the commercialisation of biotech and medtech innovations, beyond the Regulatory Clearances, i.e. Health Economics, Reimbursement, Distribution and most importantly Adoption. Med2Mark thoroughly assesses the commercial value of Health-Tech innovations before significant investments are committed. We are an international boutique Consulting Practice with over twenty years' experience in the commercialisation of Biotech and Medtech innovations in the USA, Europe, Asia and Australia
Technologies
Route 53
Gmail
Google Apps
Hotjar
Google Tag Manager
Mobile Friendly
Linkedin Login
WordPress.org
Google Font API
Linkedin Widget
Android
IoT
Node.js
Keywords
management kpis
strategic planning
health economics
medical technologies
adoption
biotechnologies
key opinion leaders
strategic alliances
private equity
sales incentives
startup
venture capital
distribution
reimbursement
commercialisation
product launch
market development
healthcare market entry
market access
diagnostic tools
personalized medicine
healthcare innovation
early adoption strategies
biotechnology
health impact assessment
b2b
digital health
medical standards compliance
nice meta tool
market assessment
Company Information
-
Employees 1
-
Founded 2011
Location
49 Studley Park Rd, Melbourne, Victoria, Australia, 3101
